EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor‐Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction

Nan Young Bae iD, Soongu Kwak iD, Chan Soon Park iD, Jiesuck Park iD, Hong-Mi Choi iD, Yeonyee E Yoon iD, Yong-Jin Kim iD, Jun-Bean Park iD, Seung-Pyo Lee iD, In-Chang Hwang iD, Hyung-Kwan Kim iD

Journal of the American Heart Association · 20.10.2026 · 15 (20)

DOI: 10.1161/jaha.126.051306 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 20.10.2026. Verfasst von Nan Young Bae und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center Seoul National University Hospital Seoul Republic of Korea. Hauptthemen laut MEDLINE: Aminobutyrates, Angiotensin Receptor Antagonists, Heart Failure, Neprilysin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac reverse remodeling and associated clinical outcomes following angiotensin receptor‐neprilysin inhibitor (ARNI) therapy in patients with heart failure (HF) with reduced ejection fraction (EF) remain unclear. We investigated differences in 1‐year echocardiographic response after ARNI therapy and predictors of clinical outcomes.

Methods

This study involved patients with HF with reduced EF and ARNI therapy for more than 6 months, using data from a 2‐center registry. Echocardiographic data were analyzed at baseline and 1 year after ARNI initiation. Responders were defined as patients with a ≥30% reduction in left ventricular end‐systolic volume at 1 year; all others were nonresponders. The primary outcome was cardiovascular death, and secondary outcomes were hospitalization for HF and all‐cause death. Time‐by‐group interactions in echocardiographic parameters were evaluated using linear mixed‐effects models.

Results

Among 1002 patients (mean age: 64.2±13.7 years; 70.8% men), 451 (45.0%) were responders and 551 (55.0%) were nonresponders. Responders had a lower baseline left ventricular EF but higher left ventricular EF at 1 year (27.0% [95% CI, 22.0–33.0] and 48.0% [95% CI, 42.0–55.0]). Both groups showed improvements in diastolic parameters, with more pronounced changes in responders. In multivariable analysis, nonresponders had a significantly higher risk of cardiovascular death, hospitalization for HF, and all‐cause death (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminobutyratesAngiotensin Receptor AntagonistsHeart FailureNeprilysinStroke VolumeVentricular Function, LeftVentricular RemodelingAgedFemaleHumansMaleMiddle AgedBiphenyl CompoundsEchocardiographyHospitalizationRecovery of FunctionRegistriesTetrazolesTime FactorsTreatment Effect HeterogeneityTreatment OutcomeValsartan

Stichwörter der Autor:innen

angiotensin receptor‐neprilysin inhibitorcardiac reverse remodelingheart failure with reduced ejection fraction

Substanzen

AminobutyratesAngiotensin Receptor AntagonistsBiphenyl CompoundsNeprilysinTetrazolesValsartan

Autor:innen und Institutionen

  • Cardiovascular Center Seoul National University Hospital Seoul Republic of Korea.
  • Department of Internal Medicine Seoul National University College of Medicine Seoul Republic of Korea.
  • Cardiovascular Center Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Republic of Korea.

ORCID-Profile: Nan Young Bae, Soongu Kwak, Chan Soon Park, Jiesuck Park, Hong-Mi Choi, Yeonyee E Yoon, Yong-Jin Kim, Jun-Bean Park, Seung-Pyo Lee, In-Chang Hwang, Hyung-Kwan Kim

Zitieren

APA

Bae, N. Y., Kwak, S., Park, C. S., Park, J., Choi, H. M., Yoon, Y. E., Kim, Y. J., Park, J. B., Lee, S. P., Hwang, I. C., & Kim, H. K. (2026). Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor‐Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association, 15(20). https://doi.org/10.1161/jaha.126.051306

Vancouver

Bae NY, Kwak S, Park CS, Park J, Choi HM, Yoon YE, et al. Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor‐Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association. 2026;15(20). doi:10.1161/jaha.126.051306

BibTeX
@article{Bae2026,
  author = {Bae, Nan Young and Kwak, Soongu and Park, Chan Soon and Park, Jiesuck and Choi, Hong-Mi and Yoon, Yeonyee E and Kim, Yong-Jin and Park, Jun-Bean and Lee, Seung-Pyo and Hwang, In-Chang and Kim, Hyung-Kwan},
  title = {Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor‐Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {20},
  doi = {10.1161/jaha.126.051306}
}
Kostenlos starten →